Inclusion Criteria:  Patients must be 18 years of age or older at the time of enrollment High-risk multiple myeloma patients who complete pre-transplant induction treatment anti- myeloma drug combination (minimum 2 drugs).  Exclusion Criteria:  Patients who are pregnant or lactating. Patients who have any active and uncontrolled infection. No blood cultures are necessary unless clinically indicated.